MITO logo

Stealth BioTherapeutics (MITO) EBIT

MITO Annual EBIT

-$51.28 M
+$4.36 M+7.84%

31 December 2021

MITO EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MITO Quarterly EBIT

-$7.59 M
+$11.98 M+61.20%

31 March 2022

MITO Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MITO TTM EBIT

-$51.49 M
-$206.00 K-0.40%

31 March 2022

MITO TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MITO EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.8%-2.8%-7.0%
3 y3 years+31.9%+80.3%+20.9%
5 y5 years+35.6%+63.0%+20.9%

MITO EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time+0.2%-273.1%+151.2%

Stealth BioTherapeutics EBIT History

DateAnnualQuarterlyTTM
Mar 2022
-
-$7.59 M(-61.2%)
-$51.49 M(+0.4%)
Dec 2021
-$51.28 M(-7.8%)
-$19.58 M(+220.9%)
-$51.28 M(+3.3%)
Sept 2021
-
-$6.10 M(-66.5%)
-$49.66 M(-8.8%)
June 2021
-
-$18.22 M(+146.6%)
-$54.44 M(+13.1%)
Mar 2021
-
-$7.39 M(-58.8%)
-$48.13 M(-13.5%)
Dec 2020
-$55.65 M(-14.5%)
-$17.95 M(+65.0%)
-$55.65 M(+67.1%)
Sept 2020
-
-$10.88 M(-8.7%)
-$33.31 M(-13.0%)
June 2020
-
-$11.91 M(-20.1%)
-$38.30 M(-7.7%)
Mar 2020
-
-$14.90 M(-439.7%)
-$41.47 M(-36.3%)
DateAnnualQuarterlyTTM
Dec 2019
-$65.06 M(-13.7%)
$4.39 M(-127.7%)
-$65.06 M(-27.0%)
Sept 2019
-
-$15.87 M(+5.2%)
-$89.10 M(-0.8%)
June 2019
-
-$15.09 M(-60.8%)
-$89.82 M(-7.3%)
Mar 2019
-
-$38.49 M(+95.9%)
-$96.89 M(+28.6%)
Dec 2018
-$75.36 M(-5.4%)
-$19.65 M(+18.5%)
-$75.36 M(-1.1%)
Sept 2018
-
-$16.59 M(-25.1%)
-$76.20 M(+27.8%)
June 2018
-
-$22.15 M(+30.6%)
-$59.61 M(+59.1%)
Mar 2018
-
-$16.96 M(-17.2%)
-$37.46 M(+82.8%)
Dec 2017
-$79.63 M(+30.4%)
-$20.50 M
-$20.50 M
Dec 2016
-$61.05 M
-
-

FAQ

  • What is Stealth BioTherapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Stealth BioTherapeutics?
  • What is Stealth BioTherapeutics annual EBIT year-on-year change?
  • What is Stealth BioTherapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Stealth BioTherapeutics?
  • What is Stealth BioTherapeutics quarterly EBIT year-on-year change?
  • What is Stealth BioTherapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Stealth BioTherapeutics?
  • What is Stealth BioTherapeutics TTM EBIT year-on-year change?

What is Stealth BioTherapeutics annual earnings before interest & taxes?

The current annual EBIT of MITO is -$51.28 M

What is the all time high annual EBIT for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high annual earnings before interest & taxes is -$51.21 M

What is Stealth BioTherapeutics annual EBIT year-on-year change?

Over the past year, MITO annual earnings before interest & taxes has changed by +$4.36 M (+7.84%)

What is Stealth BioTherapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of MITO is -$7.59 M

What is the all time high quarterly EBIT for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high quarterly earnings before interest & taxes is $4.39 M

What is Stealth BioTherapeutics quarterly EBIT year-on-year change?

Over the past year, MITO quarterly earnings before interest & taxes has changed by -$206.00 K (-2.79%)

What is Stealth BioTherapeutics TTM earnings before interest & taxes?

The current TTM EBIT of MITO is -$51.49 M

What is the all time high TTM EBIT for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high TTM earnings before interest & taxes is -$20.50 M

What is Stealth BioTherapeutics TTM EBIT year-on-year change?

Over the past year, MITO TTM earnings before interest & taxes has changed by -$3.36 M (-6.97%)